Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after primary surgery for early breast cancer. Here, we pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet
Main Authors: Murray Brunt, Adrian, Haviland, Joanne S, Wheatley, Duncan A, Sydenham, Mark A, Alhasso, Abdulla, Bloomfield, David J, Chan, Charlie, Churn, Mark, Cleator, Susan, Coles, Charlotte E, Goodman, Andrew, Harnett, Adrian, Hopwood, Penelope, Kirby, Anna M, Kirwan, Cliona C, Morris, Carolyn, Nabi, Zohal, Sawyer, Elinor, Somaiah, Navita, Stones, Liba, Syndikus, Isabel, Bliss, Judith M, Yarnold, John R
Formato: Artigo
Idioma:Inglês
Publicado em: The Author(s). Published by Elsevier Ltd. 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262592/
https://ncbi.nlm.nih.gov/pubmed/32580883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(20)30932-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados